Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:caplaa01

Total Results:

1345


Call it what it is: Hate speech [Newspaper Article]

Caplan, Arthur L
Picking on someone as being "not religious enough" for high office or on a religion as being insufficiently pious to produce a viable candidate for any office -- from county sheriff to president -- is intolerant bias, simply out of bounds in American political discourse
PROQUEST:897303730
ISSN: 1085-6706
CID: 1489882

Time for a boycott of Chinese science and medicine pertaining to organ transplantation [Letter]

Caplan, A L; Danovitch, Gabriel; Shapiro, Michael; Lavee, Jacob; Epstein, Miran
PMID: 21962556
ISSN: 0140-6736
CID: 165197

Ethics of vaccination programs

Schwartz, Jason L; Caplan, Arthur L
Ethical issues are present at each stage in the vaccine product life cycle, the period extending from the earliest stages of research through the eventual design and implementation of global vaccination programs. Recent developments highlight fundamental principles of vaccine ethics and raise unique issues for ongoing vaccination activities worldwide. These include the 2009-10 H1N1 pandemic influenza vaccination campaign, renewed attention to the potential global eradication of polio, and the ongoing evaluation of vaccine risk controversies, most notably the alleged link between childhood vaccines and autism. These cases present ethical challenges for public health policy-makers, scientists, physicians, and other stakeholders in their efforts to improve the health of individuals, communities, and nations through vaccination.
PMID: 22440783
ISSN: 1879-6265
CID: 163916

The use of prisoners as sources of organs--an ethically dubious practice

Caplan, Arthur
The movement to try to close the ever-widening gap between demand and supply of organs has recently arrived at the prison gate. While there is enthusiasm for using executed prisoners as sources of organs, there are both practical barriers and moral concerns that make it unlikely that proposals to use prisoners will or should gain traction. Prisoners are generally not healthy enough to be a safe source of organs, execution makes the procurement of viable organs difficult, and organ donation post-execution ties the medical profession too closely to the act of execution.
PMID: 21943258
ISSN: 1526-5161
CID: 163925

Fetuses First!

Caplan, Arthur L
Caplan relates the story of a pregnant woman who attempted to kill herself by swallowing a rat poison. Her life was saved but it resulted to the death of the baby after she gave birth. She was arrested , charged with murder and attempted feticide, and sent to jail. Prosecutors called her a "cold-blooded" murderer. If convicted, she will get a minimum sentence of forty-five years. The death penalty or life in prison without parole are also possibilities. This story is disturbing not just because it is unconscionable to prosecute as a murderer a pregnant woman who tried to kill herself, but because it is likely that the case was brought to make a point in the ongoing national battle over abortion
PROQUEST:897037066
ISSN: 0272-0701
CID: 1496162

Better off living--the ethics of the new UNOS proposal for allocating kidneys for transplantation

Reese, Peter P; Caplan, Arthur L
PMID: 21896832
ISSN: 1555-9041
CID: 163927

The Stem of the Conflict

Caplan, Arthur
Some forms of stem cell research involving the use of embryos require embryo destruction to extract a stem cell. Others, involving cloning, require transferring a full set of genes from an adult cell into an egg. Both procedures have received heavy criticism from those opposed to embryo destruction or embryo creation by a technique other than sex. While there's a good deal of focus on the problems generated by the power of money in generating bias in science and medicine, the battle over stem cell research makes very clear that religious views can also be a huge source of distortion and bias. Here, Caplan talks about the ongoing debate about stem cell research in the US
PROQUEST:882239974
ISSN: 0272-0701
CID: 1496152

Time to mandate influenza vaccination in health-care workers

Caplan, Arthur
PMID: 21789789
ISSN: 0140-6736
CID: 163928

What is the evidence for our standards of care? [Editorial]

Turka, Laurence A; Caplan, Arthur
The term evidence-based medicine is overused, abused, and is beginning to ring hollow. It is not that evidence (or at least of what most people in biomedicine think evidence-based medicine should strive to be) is a bad thing. Rather, there is more rhetoric about evidence than there is actual evidence to support the degree of talk.
PMCID:3127439
PMID: 21737884
ISSN: 0021-9738
CID: 163929

Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection

Reese, Peter P; Halpern, Scott D; Asch, David A; Bloom, Roy; Nathan, Howard; Hasz, Richard; Roth, Joseph; Reitsma, William; Krefski, Louis; Goerlitz, Fred; DeLauro, Gina; Blumberg, Emily; Weng, Francis L; Caplan, Arthur; Thomasson, Arwin; Shults, Justine; Feldman, Harold I
BACKGROUND: Transmission of human immunodeficiency virus and hepatitis C to transplant recipients has drawn attention of the use of allografts from seronegative donors at increased risk for blood-borne viral infection (DIRVI). METHODS: We performed a cohort study of 7803 kidney transplant recipients whose kidneys were recovered through one of two organ procurement organizations from 1996 to 2007. Detailed organ procurement organization data on donor risk factors were linked to recipient data from the Organ Procurement and Transplantation Network. RESULTS: Median recipient follow-up was 3.9 years. Three hundred sixty-eight (5%) patients received DIRVI kidneys, a third of which were procured from donors with a history of injection drug use or commercial sex work. Compared with standard criteria kidney recipients, DIRVI kidney recipients were more likely to be human immunodeficiency virus positive or black. In multivariable Cox regression, using DIRVI recipients as the reference, recipients of standard criteria donor kidneys had lower mortality (hazard ratio [HR] 0.71, P<0.01) and no difference in death-censored allograft failure (HR 1.09, P=0.62), whereas recipients of expanded criteria donor kidneys had no significant difference in mortality (HR 0.98, P=0.83) but a higher allograft failure rate (HR 1.93, P<0.01). High-quality data on posttransplant recipient viral testing were not available. CONCLUSIONS: DIRVI kidney recipients experienced higher mortality than standard criteria kidney recipients. This finding could be explained if sicker patients received DIRVI kidneys (i.e., residual confounding) or the less likely possibility of undetected transmission of viral infections. Given the limitations of registry data used in this analysis, prospective studies are needed to further elucidate these findings.
PMCID:3462444
PMID: 21527872
ISSN: 0041-1337
CID: 163930